Reents Scott T

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 43% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Reents Scott T's trades of Abbvie Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
394.02
Quantity 97,827 -3.7%
Value US$1,854,982
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
305.91
Quantity 76,614
Value US$1,427,040
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
241.58
Quantity 88,540
Value US$4,676,389
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
177.44
Quantity 14,140 -34.3%
Value US$2,509,002
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
153.38
Quantity 850 -51.2%
Value US$130,373
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
153.06
Quantity 15,092 -90.1%
Value US$2,309,982
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-18 2025-03-14
US Abbvie Inc (ABBV)
S Sale
97,827 -3.7%
394.02
US$1,854,982 		97,827 -3.7% 394.02 US$1,854,982
2025-03-14 2025-03-14
US Abbvie Inc (ABBV)
PrS Proposed sale
76,614
305.91
US$1,427,040 		76,614 305.91 US$1,427,040
2024-03-01 2024-02-23
US Abbvie Inc (ABBV)
PrS Proposed sale
88,540
241.58
US$4,676,389 		88,540 241.58 US$4,676,389
2024-03-01 2024-02-23
US Abbvie Inc (ABBV)
S Sale
14,140 -34.3%
177.44
US$2,509,002 		14,140 -34.3% 177.44 US$2,509,002
2023-03-02 2023-03-01
US Abbvie Inc (ABBV)
S Sale
850 -51.2%
153.38
US$130,373 		850 -51.2% 153.38 US$130,373
2023-03-02 2023-03-01
US Abbvie Inc (ABBV)
S Sale
15,092 -90.1%
153.06
US$2,309,982 		15,092 -90.1% 153.06 US$2,309,982